Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hye J Chung

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Biopharmaceutics & Drug Disposition|August 12, 2006
Pharmacokinetic changes of ipriflavone in rats with acute renal failure induced by uranyl nitrateHye J Chung, Myung G Lee
Cutis|October 4, 2014
Rupioid psoriasis and other skin diseases with rupioid manifestationsHye J Chung, Daria Marley-Kemp, Matthew Keller
The American Journal of Dermatopathology|June 21, 2017
Annular Plaque on the Inner ThighHye J Chung, Santosh U Kafle, Christina Lam, et al.
Journal of Cutaneous Pathology|July 20, 2018
Linearized solar elastosis of the legs: A novel presentation and review of the literatureJudy Cheng, Jonathan Ho, Mary Barrett, et al.
The Journal of Pharmacy and Pharmacology|April 7, 2006
Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in ratsHye J Chung, Young H Choi, So H Kim, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 8, 2009
Pharmacokinetic interaction between liquiritigenin (LQ) and DDB: increased glucuronidation of LQ in the liver possibly due to increased hepatic blood flow rate by DDBHee E Kang, Hye J Chung, Hyung S Kim, et al.
Biopharmaceutics & Drug Disposition|July 11, 2009
Ipriflavone pharmacokinetics in mutant Nagase analbuminemic ratsHye J Chung, Hee E Kang, Kyung H Yang, et al.
Journal of Pharmaceutical Sciences|March 5, 2008
Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11Hye J Chung, Hee E Kang, Eun J Bae, et al.
Biopharmaceutics & Drug Disposition|September 12, 2007
Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to ratsHye D Choi, Hee E Kang, Hye J Chung, et al.
Biopharmaceutics & Drug Disposition|March 23, 2007
Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailabilityHye J Chung, Joo H Lee, Sung J Woo, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Biopharmaceutics & Drug Disposition|August 12, 2006
Pharmacokinetic changes of ipriflavone in rats with acute renal failure induced by uranyl nitrateHye J Chung, Myung G Lee
Cutis|October 4, 2014
Rupioid psoriasis and other skin diseases with rupioid manifestationsHye J Chung, Daria Marley-Kemp, Matthew Keller
The American Journal of Dermatopathology|June 21, 2017
Annular Plaque on the Inner ThighHye J Chung, Santosh U Kafle, Christina Lam, et al.
Journal of Cutaneous Pathology|July 20, 2018
Linearized solar elastosis of the legs: A novel presentation and review of the literatureJudy Cheng, Jonathan Ho, Mary Barrett, et al.
The Journal of Pharmacy and Pharmacology|April 7, 2006
Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in ratsHye J Chung, Young H Choi, So H Kim, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 8, 2009
Pharmacokinetic interaction between liquiritigenin (LQ) and DDB: increased glucuronidation of LQ in the liver possibly due to increased hepatic blood flow rate by DDBHee E Kang, Hye J Chung, Hyung S Kim, et al.
Biopharmaceutics & Drug Disposition|July 11, 2009
Ipriflavone pharmacokinetics in mutant Nagase analbuminemic ratsHye J Chung, Hee E Kang, Kyung H Yang, et al.
Journal of Pharmaceutical Sciences|March 5, 2008
Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11Hye J Chung, Hee E Kang, Eun J Bae, et al.
Biopharmaceutics & Drug Disposition|September 12, 2007
Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to ratsHye D Choi, Hee E Kang, Hye J Chung, et al.
Biopharmaceutics & Drug Disposition|March 23, 2007
Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailabilityHye J Chung, Joo H Lee, Sung J Woo, et al.
Pageof 2